ACCOLADE INC (ACCD) Fundamental Analysis & Valuation

NASDAQ:ACCD • US00437E1029

Current stock price

7.02 USD
-0.01 (-0.14%)
At close:
7.02 USD
0 (0%)
After Hours:

This ACCD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ACCD Profitability Analysis

1.1 Basic Checks

  • In the past year ACCD has reported negative net income.
  • ACCD had a negative operating cash flow in the past year.
  • In the past 5 years ACCD always reported negative net income.
  • In the past 5 years ACCD always reported negative operating cash flow.
ACCD Yearly Net Income VS EBIT VS OCF VS FCFACCD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -100M -200M -300M -400M

1.2 Ratios

  • With a Return On Assets value of -27.85%, ACCD is not doing good in the industry: 83.02% of the companies in the same industry are doing better.
  • ACCD's Return On Equity of -57.60% is on the low side compared to the rest of the industry. ACCD is outperformed by 72.64% of its industry peers.
Industry RankSector Rank
ROA -27.85%
ROE -57.6%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACCD Yearly ROA, ROE, ROICACCD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

  • Looking at the Gross Margin, with a value of 48.15%, ACCD is in the better half of the industry, outperforming 75.47% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ACCD has grown nicely.
  • The Profit Margin and Operating Margin are not available for ACCD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.11%
GM growth 5Y5.22%
ACCD Yearly Profit, Operating, Gross MarginsACCD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ACCD Health Analysis

2.1 Basic Checks

  • ACCD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for ACCD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ACCD Yearly Shares OutstandingACCD Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 20M 40M 60M
ACCD Yearly Total Debt VS Total AssetsACCD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

  • ACCD has an Altman-Z score of -1.06. This is a bad value and indicates that ACCD is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of ACCD (-1.06) is worse than 82.08% of its industry peers.
  • A Debt/Equity ratio of 0.67 indicates that ACCD is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.67, ACCD perfoms like the industry average, outperforming 55.66% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Altman-Z -1.06
ROIC/WACCN/A
WACC7.47%
ACCD Yearly LT Debt VS Equity VS FCFACCD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • ACCD has a Current Ratio of 2.63. This indicates that ACCD is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.63, ACCD belongs to the top of the industry, outperforming 81.13% of the companies in the same industry.
  • ACCD has a Quick Ratio of 2.63. This indicates that ACCD is financially healthy and has no problem in meeting its short term obligations.
  • ACCD has a Quick ratio of 2.63. This is amongst the best in the industry. ACCD outperforms 81.13% of its industry peers.
Industry RankSector Rank
Current Ratio 2.63
Quick Ratio 2.63
ACCD Yearly Current Assets VS Current LiabilitesACCD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ACCD Growth Analysis

3.1 Past

  • ACCD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.76%, which is quite impressive.
  • Looking at the last year, ACCD shows a quite strong growth in Revenue. The Revenue has grown by 14.99% in the last year.
  • The Revenue has been growing by 34.31% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)35.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.71%
Revenue 1Y (TTM)14.99%
Revenue growth 3Y34.47%
Revenue growth 5Y34.31%
Sales Q2Q%5.73%

3.2 Future

  • ACCD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.04% yearly.
  • ACCD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.82% yearly.
EPS Next Y-8.14%
EPS Next 2Y17.4%
EPS Next 3Y15.02%
EPS Next 5Y20.04%
Revenue Next Year13.05%
Revenue Next 2Y12.53%
Revenue Next 3Y12.5%
Revenue Next 5Y13.82%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ACCD Yearly Revenue VS EstimatesACCD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
ACCD Yearly EPS VS EstimatesACCD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

0

4. ACCD Valuation Analysis

4.1 Price/Earnings Ratio

  • ACCD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACCD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACCD Price Earnings VS Forward Price EarningsACCD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACCD Per share dataACCD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ACCD's earnings are expected to grow with 15.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.4%
EPS Next 3Y15.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ACCD Dividend Analysis

5.1 Amount

  • No dividends for ACCD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ACCD Fundamentals: All Metrics, Ratios and Statistics

ACCOLADE INC

NASDAQ:ACCD (4/7/2025, 8:11:12 PM)

After market: 7.02 0 (0%)

7.02

-0.01 (-0.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)01-17
Earnings (Next)04-23
Inst Owners82.6%
Inst Owner Change-92%
Ins Owners3.24%
Ins Owner Change0%
Market Cap575.57M
Revenue(TTM)446.72M
Net Income(TTM)-180.30M
Analysts53.75
Price Target6.83 (-2.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)45.01%
Min EPS beat(2)32.78%
Max EPS beat(2)57.24%
EPS beat(4)3
Avg EPS beat(4)20.09%
Min EPS beat(4)-38.53%
Max EPS beat(4)57.24%
EPS beat(8)7
Avg EPS beat(8)20.01%
EPS beat(12)10
Avg EPS beat(12)12.6%
EPS beat(16)11
Avg EPS beat(16)2.19%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)-0.7%
Revenue beat(4)1
Avg Revenue beat(4)-0.39%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)2.92%
Revenue beat(8)4
Avg Revenue beat(8)-0.07%
Revenue beat(12)8
Avg Revenue beat(12)0.64%
Revenue beat(16)12
Avg Revenue beat(16)1.56%
PT rev (1m)-3.17%
PT rev (3m)-6.66%
EPS NQ rev (1m)-35.39%
EPS NQ rev (3m)-17.28%
EPS NY rev (1m)-7.63%
EPS NY rev (3m)-53.12%
Revenue NQ rev (1m)1.92%
Revenue NQ rev (3m)1.8%
Revenue NY rev (1m)0.54%
Revenue NY rev (3m)0.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.29
P/FCF N/A
P/OCF N/A
P/B 1.84
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)-0.83
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS5.45
BVpS3.82
TBVpS-0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -27.85%
ROE -57.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.15%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.11%
GM growth 5Y5.22%
F-Score4
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 14.12%
Cap/Sales 1.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.63
Quick Ratio 2.63
Altman-Z -1.06
F-Score4
WACC7.47%
ROIC/WACCN/A
Cap/Depr(3y)17.24%
Cap/Depr(5y)23.91%
Cap/Sales(3y)2.06%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.71%
EPS Next Y-8.14%
EPS Next 2Y17.4%
EPS Next 3Y15.02%
EPS Next 5Y20.04%
Revenue 1Y (TTM)14.99%
Revenue growth 3Y34.47%
Revenue growth 5Y34.31%
Sales Q2Q%5.73%
Revenue Next Year13.05%
Revenue Next 2Y12.53%
Revenue Next 3Y12.5%
Revenue Next 5Y13.82%
EBIT growth 1Y36.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year116.25%
EBIT Next 3Y36.45%
EBIT Next 5Y25.67%
FCF growth 1Y72.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.28%
OCF growth 3YN/A
OCF growth 5YN/A

ACCOLADE INC / ACCD Fundamental Analysis FAQ

What is the fundamental rating for ACCD stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACCD.


Can you provide the valuation status for ACCOLADE INC?

ChartMill assigns a valuation rating of 0 / 10 to ACCOLADE INC (ACCD). This can be considered as Overvalued.


How profitable is ACCOLADE INC (ACCD) stock?

ACCOLADE INC (ACCD) has a profitability rating of 1 / 10.


Can you provide the financial health for ACCD stock?

The financial health rating of ACCOLADE INC (ACCD) is 4 / 10.